Singapore Research Network Named WHO Collaborating Centre for Clinical Trials
A Singapore-based regional research network has received a prestigious appointment from the World Health Organization (WHO). The organization has been officially named a WHO Collaborating Centre, a title given to institutions that support the global health body in its mission to improve medical standards.
This appointment recognizes the network’s significant contributions to high-quality clinical research. By working closely with the WHO, the Singapore team will help develop better methods for testing new medicines and treatments. This collaboration is expected to strengthen the quality of healthcare research not only in Singapore but across the entire region.
Clinical trials are essential for discovering safe and effective ways to treat diseases. As a new collaborating centre, the network will provide expert advice and technical support to help the WHO set global standards for these medical studies. This role highlights Singapore's growing importance as a hub for medical innovation and scientific excellence.
This partnership marks a positive step forward for international health cooperation. By sharing local expertise on a global stage, Singapore continues to play a vital role in advancing medical science and improving patient outcomes worldwide.